SageView Advisory Group LLC Sells 2,844 Shares of Hawkins, Inc. (NASDAQ:HWKN)

SageView Advisory Group LLC lessened its position in shares of Hawkins, Inc. (NASDAQ:HWKN) by 46.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,285 shares of the specialty chemicals company’s stock after selling 2,844 shares during the period. SageView Advisory Group LLC’s holdings in Hawkins were worth $225,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of HWKN. Swiss National Bank increased its holdings in Hawkins by 0.9% during the 3rd quarter. Swiss National Bank now owns 43,988 shares of the specialty chemicals company’s stock worth $2,589,000 after acquiring an additional 400 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Hawkins by 2.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 233,193 shares of the specialty chemicals company’s stock worth $13,723,000 after buying an additional 5,396 shares during the last quarter. Deutsche Bank AG increased its holdings in shares of Hawkins by 17.4% in the 3rd quarter. Deutsche Bank AG now owns 10,177 shares of the specialty chemicals company’s stock worth $599,000 after buying an additional 1,512 shares during the last quarter. Rhumbline Advisers increased its holdings in shares of Hawkins by 1.2% in the 3rd quarter. Rhumbline Advisers now owns 54,596 shares of the specialty chemicals company’s stock worth $3,213,000 after buying an additional 624 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of Hawkins in the 3rd quarter worth $557,000. Institutional investors own 69.71% of the company’s stock.

Insider Buying and Selling at Hawkins

In other news, Director James A. Faulconbridge purchased 1,800 shares of the company’s stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $87.56 per share, with a total value of $157,608.00. Following the transaction, the director now directly owns 40,517 shares of the company’s stock, valued at approximately $3,547,668.52. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director James A. Faulconbridge purchased 2,000 shares of the company’s stock in a transaction on Monday, June 10th. The stock was acquired at an average price of $86.47 per share, with a total value of $172,940.00. Following the transaction, the director now directly owns 44,017 shares of the company’s stock, valued at approximately $3,806,149.99. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director James A. Faulconbridge purchased 1,800 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were purchased at an average cost of $87.56 per share, with a total value of $157,608.00. Following the transaction, the director now directly owns 40,517 shares in the company, valued at $3,547,668.52. The disclosure for this purchase can be found here. Insiders bought 5,100 shares of company stock valued at $442,998 in the last quarter. Company insiders own 3.60% of the company’s stock.

Hawkins Price Performance

HWKN stock opened at $89.40 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.24 and a current ratio of 1.96. Hawkins, Inc. has a 52 week low of $45.37 and a 52 week high of $90.71. The firm’s fifty day moving average is $82.39 and its 200 day moving average is $73.91. The firm has a market cap of $1.87 billion, a P/E ratio of 24.90, a P/E/G ratio of 4.07 and a beta of 0.78.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, May 15th. The specialty chemicals company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.02). Hawkins had a net margin of 8.20% and a return on equity of 19.41%. The business had revenue of $223.02 million for the quarter, compared to the consensus estimate of $217.49 million. Research analysts predict that Hawkins, Inc. will post 3.67 earnings per share for the current year.

Hawkins Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Friday, May 31st were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 0.72%. The ex-dividend date of this dividend was Friday, May 31st. Hawkins’s dividend payout ratio is currently 17.83%.

Analysts Set New Price Targets

Separately, BWS Financial increased their price target on shares of Hawkins from $74.00 to $96.00 and gave the stock a “buy” rating in a report on Friday, May 17th.

Hawkins Company Profile

Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.